MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202617054266 A) filed by Graviton Pharmaceuticals B. V. on April 28, 2026, for Therapy For Treating Type 1 Diabetes Using Rock2 And Dyrk1 Inhibitors.
Inventors include Waksal, Samuel D.; and Vilenchik, Maria.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: The present disclosure relates to therapies for preventing and/or treating type 1 diabetes. The present disclosure provides combination therapies for treating type 1 diabetes using a Rho-associated coiled coil containing protein kinase 2 (ROCK2) inhibitor and a dual specificity tyrosine-phosphorylation-regulated kinase 1 (DYRK1) inhibitor. Also, provided are methods for using the combination of a ROCK2 and a DYRK1 inhibitor and kits using the same. Also provided are methods of preventing the progression or development of type 1 diabetes by administering a ROCK2 inhibitor.
Disclaimer: Curated by HT Syndication.
